"As previously advised, C14 is working with Biotron to refine...

"As previously advised, C14 is working with Biotron to refine its commercialisation strategy and provide business development support over the coming months. The project and retainer fees together with an outcome-based success component aligns the interests of the parties in achieving
one or more commercial outcomes "

How many times will the same “project and retainer fees” be copied and pasted into announcements? It’s as if the only work being done by management is recycling old content from previous ASX releases. No progress. No delivery. Just repetition.

Meanwhile, the longer C14 drags this out, the more shareholder money is burned — in the form of fees paid to C14, to the CEO, and to others benefiting from delay rather than delivery.

Their silence isn’t just disappointing — it’s costly. The company continues paying management, especially Michelle, while no meaningful updates or milestones are achieved. A rational person would ask: why is Michelle still drawing a salary during this prolonged period of silence? And more importantly, what has she tangibly delivered since 2024 to justify it?

Since 2024, every dollar paid to her in salary has effectively been wasted — shareholder money flushed away like toilet paper, with nothing of substance to show for it.